samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > innovative facility concepts for biopharmaceutical multipurpose pilot and production plants
PUBLICATIONS
European Biopharmaceutical Review

Innovative Facility Concepts for Biopharmaceutical Multipurpose Pilot and Production Plants

The manufacturing requirements of biologics, raw materials, starting materials, excipients and APIs (secondary metabolite, prokaryat, cell culture, transgenic plants and animals, blood products, vaccines and so on), and the dosage form required (aseptic filling, vials, ampoules, syringes, pulmonary systems, transdermal systems etcetera), strongly influence the design concept for pharmaceutical facilities. The greatest influential factors on the design of such facilities are the purpose of the plant (mono or multipurpose), and the size of the plant (the production of cytokines requires less equipment and equipment that is smaller than bulk or rHSA, for example). The production of clinical trial material also needs a smaller plant than for market supply.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Hermann Allgaier, Managing Director of Operations at LSMW GmbH
Dr Hermann Allgaier is the Managing Director of Operations for LSMW GmbH, a company providing consultancy, design, construction and validation services for the pharmaceutical and biotech industry. His 17 years of experience include upstream and downstream processing, engineering, analytical services and internal compliance. He was Responsible Head and led the worldwide process development of new chemical entities at Boehringer Ingelheim in Germany.

Dr Allgaier has made numerous presentations and has had work published in the
areas of biopharmaceutical development, manufacturing and general compliance. He is a Member of PDA, ISPE and APV, where he heads the biopharmaceutical section. Dr Allgaier studied Biochemistry at the University of Tübingen, where he received the Friedrich Weygand Award for his PhD work in the field of peptide antibiotics.

spacer
Dr Hermann Allgaier
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera reinforces its value proposition with a refreshing visual identity

At Nemera, we have been successfully providing high quality drug delivery device solutions to our customers and patients for years. We design and manufacture devices with the ultimate goal to improve patient outcomes and experience.
More info >>

White Papers

Sterile Vials Made of Tubular Glass

Gerresheimer AG

Gx® RTF vials powered by Ompi EZ-fill® enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and ready-to-fill processing for our pharma and biotech customers.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement